title: Long-term follow-up in a patient with the dermato-neuro syndrome treated with high-dose melphalan, thalidomide, and intravenous immunoglobulins for more than 7 years.
authors.affiliation: Department of Hematology, University Hospitals Leuven, Leuven, Belgium, Timothy.Devos@uzleuven.be.
authors.forename: T
authors.initials: T
authors.lastname: Devos
authors.forename: S
authors.initials: S
authors.lastname: Thiessen
authors.forename: P J
authors.initials: PJ
authors.lastname: Cuyle
authors.forename: W
authors.initials: W
authors.lastname: Meersseman
authors.forename: M
authors.initials: M
authors.lastname: Delforge
mesh_terms: D000328:Adult; D005500:Follow-Up Studies; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008558:Melphalan / Q000008:administration & dosage / Q000009:adverse effects*; D009422:Nervous System Diseases / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D053718:Scleromyxedema / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D033581:Stem Cell Transplantation / Q000009:adverse effects* / Q000639:trends; D013577:Syndrome; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D016756:Immunoglobulins, Intravenous; D013792:Thalidomide; D008558:Melphalan